Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixabepilone in Recurrent Uterine Leiomyosarcoma
NCT01220609Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Nov 2010
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixabepilone in uterine leiomyosarcoma (uLMS), sponsored by National Cancer Institute. Started Nov 2010; status: completed.
02
Drugs
ixabepilone
03
Conditions
uterine leiomyosarcoma (uLMS)
Beyond the preview
Go deeper on NCT01220609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01220609.